Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1116 | 1116 | 1157 | 1269 | 1780 | 3305 |
Fund Return | 11.62% | 11.62% | 15.69% | 8.26% | 12.23% | 12.7% |
Place in category | 51 | 51 | 61 | 169 | 16 | 50 |
% in Category | 5 | 5 | 7 | 34 | 6 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Schroder Global Equity Fund I Inc | 1.6B | 7.04 | 11.70 | 13.07 | ||
Schroder Global Equity Fund I Acc | 1.6B | 7.06 | 11.71 | 13.08 | ||
Schroder Asian Income Z Acc | 1.3B | 3.47 | 2.42 | 8.63 | ||
Schroder Asian Income Z Inc | 1.3B | 3.46 | 2.43 | 8.64 | ||
Alpha Plus Fund L GBP Accumulation | 1.29B | -0.52 | -5.45 | 9.07 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.84B | 7.74 | 9.50 | 13.38 | ||
Wellington Global Health Care EquiG | 2.45B | 5.25 | 5.27 | 13.12 | ||
Global Health Care Fund W Acc GBP | 115.74M | -8.92 | 12.63 | 14.43 | ||
Adamant Medtech I GBP | 1.53B | 10.64 | 6.33 | 14.31 | ||
Pharmaceuticals Index Trust F Acc | 254.79K | 8.14 | 10.01 | 11.74 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.59 | 732.80 | +1.09% | |
Merck&Co | US58933Y1055 | 6.33 | 131.19 | +0.36% | |
Thermo Fisher Scientific | US8835561023 | 5.23 | 573.58 | +0.32% | |
Elevance Health | US0367521038 | 3.71 | 537.37 | -0.43% | |
UnitedHealth | US91324P1021 | 3.68 | 495.42 | +0.32% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review